Doty J. D., Mazur J. E., Judson M. A.. Treatment of sarcoidosis with infliximab. CHEST 2005; 127 (3):1064-1071.
Doty J. D., Mazur J. E., Judson M. A.. Treatment of sarcoidosis with infliximab. Chest 2005; 127 (3):1064-71.
Dozier Thomas S., Duncan Irenee M., Klein Alan J., Lambert Paul R., Key L. Lyndon Jr.. Otologic manifestations of malignant osteopetrosis. Otology and Neurotology 2005; 26 (4):762-6.
Drobes D. J., Munafo M. R., Leigh F., Saladin M. E.. A family smoking index to capture genetic influence in smoking: Rationale and two validation studies. Nicotine and Tobacco Research 2005; 7 (1):41-46.
Drummond F. E., Doelken P., Frye M. D.. Empiric treatment of clinically diagnosed obstructive sleep apnea using auto-titrating continuous positive airway pressure. Chest 2005; 128 (4):223S-223S.
Dubno J. R., Horwitz A. R., Ahlstrom J. B.. Recognition of filtered words in noise at higher-than-normal levels: decreases in scores with and without increases in masking. Journal of the Acoustical Society of America 2005; 118 (2):923-33.
Dubno J. R., Horwitz A. R., Ahlstrom J. B.. Word recognition in noise at higher-than-normal levels: decreases in scores and increases in masking. Journal of the Acoustical Society of America 2005; 118 (2):914-22.
Duffy F. F., Narrow W., West J. C., Fochtmann L. J., Kahn D. A., Suppes T., Oldham J. M., McIntyre J. S., Manderscheid R. W., Sirovatka P., Regier D.. Quality of care measures for the treatment of bipolar disorder. PSYCHIATRIC QUARTERLY 2005; 76 (3):213-230.
Dulaney P., Stanley K. M.. Accomplishing change in treatment strategies. Journal of Addictions Nursing 2005; 16 (4):163-167.
Dulaney Peggy, Stanley Karen M.. Accomplishing change in treatment strategies. Journal of Addictions Nursing 2005; 16 (4):163-167.
Dulaney Peggy, Stanley Karen M.. Accomplishing change in treatment strategies. Journal of Addictions Nursing 2005; 16 (4):163-167.
Dunnick A. L., Beeson C.. Synthesis and evaluation of cephalosporin-based immunoconjugates for targeted delivery of metal chelates. FASEB JOURNAL 2005; 19 (5):A1404-A1405.
Duvall M. R., Hwang H. Y., Yang X. F., Boackle R.. Targeting the first component of complement to HIV-1 gp120 using an engineered single-chain bi-specific antibody. FASEB JOURNAL 2005; 19 (4):A35-A35.
Edelman P. D., McFarland D. C., Mironov V. A., Matheny J. G.. In vitro-cultured meat production. Tissue Engineering 2005; 11 (5-6):659-662.
Egan B. M., Basile J., Chilton R. J., Cohen J. D.. Cardioprotection: the role of beta-blocker therapy. Journal of Clinical Hypertension 2005; 7 (7):409-16.
Egan B. M., Papademetriou V., Wofford M., Calhoun D., Fernandes J., Riehle J. E., Nesbitt S., Michelson E., Julius S.. Metabolic syndrome and insulin resistance in the TROPHY Sub-Study: Contrasting views in patients with high-normal blood pressure. American Journal of Hypertension 2005; 18 (1):3-12.
Egan B. M., Papademetriou V., Wofford M., Calhoun D., Fernandes J., Riehle J. E., Nesbitt S., Michelson E., Julius S., Team Trophy Sub-study Investigative. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. American Journal of Hypertension 2005; 18 (1):3-12.
Egede L. E.. Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosomatic Medicine 2005; 67 (1):46-51.
Egede L. E.. Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosomatic Medicine 2005; 67 (1):46-51.
Egede L. E.. Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes. Curr Diabetes Rev. 2005; 1 (3):235-43..
Egede L. E., Dagogo-Jack S.. Epidemiology of type 2 diabetes: Focus on ethnic minorities. Medical Clinics of North America 2005; 89 (5):949-+.
Egede L. E., Nietert P. J., Zheng D.. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. DIABETES CARE 2005; 28 (6):1339-1345.
Egede L. E., Nietert P. J., Zheng D.. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005; 28 (6):1339-45.
Egede Leonard E., Dagogo-Jack Samuel. Epidemiology of type 2 diabetes: focus on ethnic minorities. Medical Clinics of North America 2005; 89 (5):949-75.
Egede Leonard E., Nietert Paul J., Zheng Deyi. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005; 28 (6):1339-1345.
Eicher D. J., Wagner C. L., Katikaneni L. P., Hulsey T. C., Bass W. T., Kaufman D. A., Horgan M. J., Languani S., Bhatia J. J., Givelichian L. M., Sankaran K., Yager J. Y.. Moderate hypothermia in neonatal encephalopathy: Efficacy outcomes. Pediatric Neurology 2005; 32 (1):11-17.
Eicher D. J., Wagner C. L., Katikaneni L. P., Hulsey T. C., Bass W. T., Kaufman D. A., Horgan M. J., Languani S., Bhatia J. J., Givelichian L. M., Sankaran K., Yager J. Y.. Moderate hypothermia in neonatal encephalopathy: Safety outcomes. Pediatric Neurology 2005; 32 (1):18-24.
Eisenberg L. M., Moreno R., Markwald R. R.. Multiple stem cell populations contribute to the formation of the myocardium. In: , editor. Communicative Cardiac Cell. : , 2005. p. 38-49.
Eisenberg Leonard M., Moreno Ricardo, Markwald Roger R.. Multiple stem cell populations contribute to the formation of the myocardium. Annals of the New York Academy of Sciences 2005; 1047 ():38-49.
El-Zawahry A., McKillop J., Voelkel-Johnson C.. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. Bmc Cancer 2005; 5 ():.
El-Zawahry Ahmed, McKillop John, Voelkel-Johnson Christina. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. BMC Cancer 2005; 5 (1):2.
Elhai J. D., Kashdan T. B., Frueh B.. What is a traumatic event?. British Journal of Psychiatry 2005; 187 ():189-190.
Elhai J., Gray M., Naifeh J., Butcher J., Davis J., Falsetti S., Best C.. Utility of the trauma symptom inventory's atypical response scale in detecting malingered post-traumatic stress disorder. ASSESSMENT 2005; 12 (2):210-219.
Elhai J., Kashdan T., Frueh B.. What is a traumatic event?. British Journal of Psychiatry 2005; 187 (2):189-190.
Elhai Jon D., North Terry C., Frueh B.. Health service use predictors among trauma survivors: A critical review. Psychological Services 2005; 2 (1):3-19.
Ellett J. D., Evans Z. P., Lu B., Fiorini R. N., Birsner J., Chavin K. D.. Papworth cocktail: More stable donors, but at what cost?. American Journal of Transplantation 2005; 5 ():182-182.
Ellis C., Rosenbek J. C., Rittman M. R., Boylstein C. A.. Recovery of cohesion in narrative discourse after left-hemisphere stroke. Journal of Rehabilitation Research and Development 2005; 42 (6):737-746.
Ellis C., Rosenbek J. C., Rittman M. R., Boylstein C. A.. Recovery of cohesion in narrative discourse after left-hemisphere stroke. Journal of Rehabilitation Research and Development 2005; 42 (6):737-46.
Ellis D. A., Frey M. A., Naar-King S., Templin T., Cunningham P. B., Cakan N.. The effects of multisystemic therapy on diabetes stress among adolescents with chronically poorly controlled type 1 diabetes: Findings from a randomized, controlled trial. PEDIATRICS 2005; 116 (6):E826-E832.
Ellis D. A., Naar-King S., Frey M., Templin T., Rowland M., Cakan N.. Multisystemic treatment of poorly controlled type 1 diabetes: Effects on medical resource utilization. Journal of Pediatric Psychology 2005; 30 (8):656-666.
Ellis Deborah A., Naar-King Sylvie, Frey Maureen, Templin Thomas, Rowland Melisa, Cakan Nedim. Multisystemic treatment of poorly controlled type 1 diabetes: Effects on medical resource utilization. Journal of Pediatric Psychology 2005; 30 (8):656-666.
Elm J. J., Goetz C. G., Ravina B., Shannon K., Wooten G. F., Tanner C. M., Palesch Y. Y., Huang P., Guimaraes P., Kamp C., Tilley B. C., Kieburtz K.. A responsive outcome for Parkinson's disease neuroprotection futility studies. Annals of Neurology 2005; 57 (2):197-203.
Elm J. J., Goetz C. G., Ravina B., Shannon K., Wooten G. F., Tanner C. M., Palesch Y. Y., Huang P., Guimaraes P., Kamp C., Tilley B. C., Kieburtz K., Investigators Net-Pd. A responsive outcome for Parkinson's disease neuroprotection futility studies. Annals of Neurology 2005; 57 (2):197-203.
Ervadi-Radhakrishnan A., Voit E. O.. Controllability of non-linear biochemical systems. Mathematical Biosciences 2005; 196 (1):99-123.
Ervadi-Radhakrishnan Anandhi, Voit Eberhard O.. Controllability of non-linear biochemical systems. Mathematical Biosciences 2005; 196 (1):99-123.
Ervin L. A., Ball L. E., Crouch R. K., Schey K. L.. Phosphorylation and glycosylation of bovine lens MP20. Investigative Ophthalmology and Visual Science 2005; 46 (2):627-635.
Escobar G. P., Sheats N. J., Mains I. M., McClister D. M., Lindsey M. L.. Connexin 43 is a novel matrix metalloproteinase-7 substrate: In silico, in vitro, and in vivo cleavage analyses. Circulation 2005; 112 (17):U168-U169.
Espinola R. G., Pixley R. A., Ghebrehiwet B., Joseph K., Kuo A., Cines D. B., Colman R. W.. Interaction of high molecular weight kininogen with endothelial cell receptors suPAR, gC1qR and cytokeratin 1 by surface plasmon resonance (BiaCore). Blood 2005; 106 (11):748A-748A.
Everett C. J., Mainous A. G. 3rd, Koopman R. J., Diaz V. A.. Predicting coronary heart disease risk using multiple lipid measures. AMERICAN JOURNAL OF CARDIOLOGY 2005; 95 (8):986-8.
Everett C. J., Mainous A. G. III, Koopman R. J., Diaz V. A.. Predicting coronary heart disease risk using multiple lipid measures. AMERICAN JOURNAL OF CARDIOLOGY 2005; 95 (8):986-8.
